Skip to content

A Study on the Therapeutic Effect of Pressing MTrPs Combined with Moxibustion on Athletes with Waist and Back Muscle Fascia Pain Syndrome

A Study on the Therapeutic Effect of Pressing MTrPs Combined with Moxibustion on Athletes with Waist and Back Muscle Fascia Pain Syndrome

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075495
Enrollment
Unknown
Registered
2023-09-06
Start date
2023-09-06
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar and dorsal fascial pain syndrome

Interventions

experimental group:Pressing MTrPs combined with moxibustion
control group:Pressing MTrPs
control group:Moxibustion MTrPs

Sponsors

School of Physical Education, Southwest University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: (1) Must be an athlete aged 18-30 and participate in at least two or more training or competitions per week; (2) All participants have at least three years of experience in sports training; (3) In the morning, the pain in the lower back worsens, but after slight activity, the pain alleviates, and the symptoms worsen after the lower back muscles do work (4) Due to changes in weather conditions such as thunder, rain, and being in a humid area, pain is evident, and a cord like nodule can be touched at the painful area. Pressing may cause tenderness or involve pain; (5) Visual simulation score VAS = 3 points, with daily or almost daily pain; (6) Able to receive treatment and cooperate with the implementation of full process research, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those who have received treatment or are currently receiving treatment within the past 6 months; (2) Patients with acute traumatic diseases, severe osteoporosis, tuberculosis, tumors, as well as severe cardiovascular and cerebrovascular diseases and psychiatric disorders; (3) Diagnosed or treated with fibrofibroids, or any vascular or neurological disease; (4) Patients with lower back skin infections; (5) Women who are breastfeeding, pregnant, or preparing for pregnancy.

Design outcomes

Primary

MeasureTime frame
Visual Simulation Scoring (vas);the Oswestry Disbility Index;Infrared thermal imaging technology;

Countries

China

Contacts

Public ContactHuang XiaoDong

School of Physical Education, Southwest University, Beibei District, Chongqing

3122706795@qq.com+86 158 9275 8709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026